Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis.

Journal of hepatology - 1 Feb 2013

Trebicka Jonel, Anadol Evrim, Elfimova Natalia, Strack Ingo, Roggendorf Michael, Viazov Sergei, Wedemeyer Inga, Drebber Uta, Rockstroh Jürgen, Sauerbruch Tilman, Dienes Hans-Peter, Odenthal Margarete

Abstract excerpt

BACKGROUND & AIMS: The progression of liver fibrosis in patients with chronic hepatitis C (CHC) is important to decide on the treatment of the virus. As liver biopsy and liver stiffness measurement for staging of fibrosis present limitations, circulating levels of miR-122 have been suggested as a novel biomarker to predict the extent of liver injury. We evaluated the potential of miR-122 as an indicator of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Liver Cirrhosis

Share to MicroRNAs

Share to Severity of Illness Index

Source

Identifiers

PMID: 23085648
DOI: 10.1016/j.jhep.2012.10.015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis.PMID 23085648Read ↗

Evaluation of miR-122 Serum Level and IFN-λ3 Genotypes in Patients with Chronic HCV and HCV-Infected Liver Transplant Candidate.Semantic proximity Read ↗

Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C.Semantic proximity Read ↗

MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection.Semantic proximity Read ↗

Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C.Semantic proximity Read ↗

Parallel expression profiling of hepatic and serum microRNA-122 associated with clinical features and treatment responses in chronic hepatitis C patientsSemantic proximity Read ↗

Unraveling the Mysterious Interactions Between Hepatitis C Virus RNA and Liver-Specific MicroRNA-122Semantic proximity Read ↗

Circulating microRNA-122 in HCV Cirrhotic Patients with High Frequency of Genotype 3Semantic proximity Read ↗

Severity of hepatitis C virus (genotype-3) infection positively correlates with circulating microRNA-122 in patients sera.Semantic proximity Read ↗

Circulating miR-122 as a Potential Biomarker of Liver DiseaseSemantic proximity Read ↗

Circulating microRNA-122 in HCV cirrhotic patients with high frequency of genotype 3.Semantic proximity Read ↗

Hepatitis C virus' Achilles' heel--dependence on liver-specific microRNA miR-122.Semantic proximity Read ↗

Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus InfectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.